My research focus is using genetic epidemiology to tease apart the interplay of genetic, environmental and accessibility factors to isolate the genetic contribution to the gap in disparities in treatment and health outcomes in admixed populations, particularly those of West African descent. From the identification of these genetic markers, we can then create panels of markers that predict disease risk and drug efficacy in addition to identifying genes and biological pathways that may lead to the development of treatments to ameliorate or cure diseases.